Clin2
NCT07208305Possibly a fitRecruiting

Testing a drug combo for opioid-related nausea

NauseaVomiting

Treatments studied

Part of Digestive system clinical trials.

This study tests whether the combination of olanzapine and metoclopramide can prevent nausea and vomiting caused by strong painkillers (opioids) in people with advanced cancer. If you are starting a strong opioid for pain and have not had nausea or vomiting recently, this study may be for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
222 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must have advanced cancer that is causing moderate to severe pain (a score of 4 or more out of 10 on a pain scale).
  • You must be starting a strong opioid painkiller (like morphine or oxycodone) for the first time.
  • You must be at least 18 years old and able to swallow pills.
  • You should not have had nausea, vomiting, or an intestinal blockage recently.
  • You must not have had chemotherapy or radiation in the last month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07699276Recruiting· Phase 2
Steroid-sparing nausea drug combo for high-dose chemo

This trial tests if combining two anti-nausea drugs (olanzapine and palonosetron) can prevent vomiting and nausea without using steroids in people receiving high-dose cisplatin chemotherapy for their first time.

Bangkok
NCT06338683Recruiting· Phase 3
Olanzapine for advanced upper digestive and lung cancer survival

This study tests whether a medicine called olanzapine can improve survival in people with advanced cancers of the upper digestive system or lungs. Olanzapine may help with appetite and weight, which are common problems in these cancers.

Xining, Qinghai
NCT06200181Recruiting· Phase 3
Olanzapine for opioid misuse in cancer pain

This study tests if a medication called olanzapine can help reduce cravings and misuse of opioid pain medicines in people with cancer pain. You would take olanzapine or a placebo daily for a few weeks while continuing your usual care.

Houston, Texas
NCT06850454Recruiting· Phase 3
Olanzapine vs placebo for nausea from first chemo

This study tests if the drug olanzapine (commonly used for nausea) can help prevent vomiting in people receiving moderately strong chemotherapy for the first time. It may be a good fit if you're about to start treatment with oxaliplatin, irinotecan, or carboplatin and haven't had severe nausea treatments before.

Bangkok, Bangkok
NCT07581405Not yet recruiting· Phase 2
Olanzapine to Help with Side Effects During Gastric Cancer Treatment

This trial tests whether a medication called olanzapine can help reduce nausea and loss of appetite in patients receiving chemotherapy before surgery for stomach cancer. The goal is to help you feel better and maintain nutrition during your cancer treatment.

Chicago, Illinois
NCT07246187Recruiting· Phase 3
Comparing two drugs for cannabis-related nausea in the ER

This trial tests whether haloperidol or olanzapine works better to stop severe nausea and vomiting caused by heavy cannabis use. If you use cannabis nearly daily and have had episodes of vomiting that come and go, this study may help find the best treatment for you.

Toledo, Ohio

Hear when a new Nausea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.